Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705563200 on September 21, 2007

J. Biol. Chem., Vol. 282, Issue 48, 34968-34976, November 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/48/34968    most recent
M705563200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jäger, D.
Right arrow Articles by Mohr, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jäger, D.
Right arrow Articles by Mohr, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Allosteric Small Molecules Unveil a Role of an Extracellular E2/Transmembrane Helix 7 Junction for G Protein-coupled Receptor Activation*Formula

Dorothea Jäger{ddagger}1, Caroline Schmalenbach{ddagger}1, Stefanie Prilla{ddagger}, Jasmin Schrobang§, Anna Kebig{ddagger}2, Matthias Sennwitz{ddagger}, Eberhard Heller, Christian Tränkle{ddagger}, Ulrike Holzgrabe, Hans-Dieter Höltje§, and Klaus Mohr{ddagger}3

From the {ddagger}Pharmacology and Toxicology Section, Institute of Pharmacy, Rheinische Friedrich-Wilhelms-University, D-53121 Bonn, Germany, the §Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University, D-40225 Düsseldorf, Germany, and the Department of Pharmaceutical Chemistry, Institute of Pharmacy, Julius-Maximilians-University, D-97074 Würzburg, Germany

G protein-coupled receptors represent the largest superfamily of cell membrane-spanning receptors. We used allosteric small molecules as a novel approach to better understand conformational changes underlying the inactive-to-active switch in native receptors. Allosteric molecules bind outside the orthosteric area for the endogenous receptor activator. The human muscarinic M2 acetylcholine receptor is prototypal for the study of allosteric interactions. We measured receptor-mediated G protein activation, applied a series of structurally diverse muscarinic allosteric agents, and analyzed their cooperative effects with orthosteric receptor agonists. A strong negative cooperativity of receptor binding was observed with acetylcholine and other full agonists, whereas a pronounced negative cooperativity of receptor activation was observed with the partial agonist pilocarpine. Applying a newly synthesized allosteric tool, point mutated receptors, radioligand binding, and a three-dimensional receptor model, we found that the deviating allosteric/orthosteric interactions are mediated through the core region of the allosteric site. A key epitope is M2Trp422 in position 7.35 that is located at the extracellular top of transmembrane helix 7 and that contacts, in the inactive receptor, the extracellular loop E2. Trp 7.35 is critically involved in the divergent allosteric/orthosteric cooperativities with acetylcholine and pilocarpine, respectively. In the absence of allosteric agents, Trp 7.35 is essential for receptor binding of the full agonist and for receptor activation by the partial agonist. This study provides first evidence for a role of an allosteric E2/transmembrane helix 7 contact region for muscarinic receptor activation by orthosteric agonists.


Received for publication, July 6, 2007 , and in revised form, September 4, 2007.

* The work was supported by the Deutsche Forschungsgemeinschaft (Mo821/1-4, Ho1368/7-3). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S6.

1 These authors contributed equally to this work.

2 Member of Research Training Group GRK677.

3 To whom correspondence should be addressed: Pharmacology and Toxicology Section, Institute of Pharmacy, Gerhard-Domagk-Str.3, D-53121 Bonn, Germany. Tel.: 49-228-739103; Fax: 49-228-739215; E-mail: k.mohr{at}uni-bonn.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
J. Antony, K. Kellershohn, M. Mohr-Andra, A. Kebig, S. Prilla, M. Muth, E. Heller, T. Disingrini, C. Dallanoce, S. Bertoni, et al.
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity
FASEB J, February 1, 2009; 23(2): 442 - 450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement